-
The National Medical Insurance Administration issued a blockbuster document!
Time of Update: 2021-07-06
On June 15, the National Medical Insurance Administration issued an announcement on the public consultation of the "Medical Security Law (Draft for Solicitation of Comments)" . "Medical Security Ac
-
The State Food and Drug Administration issued an announcement on protected varieties of traditional Chinese medicines
Time of Update: 2021-07-06
On May 26, the State Food and Drug Administration issued an announcement on protected varieties of traditional Chinese medicines .
will continue to be given 2 Level of protection, the protection period and the number of protected varieties are respectively May 06, 2021-May 9, 2027, ZYB20720200101 .
-
The National Bureau of Disease Control and Prevention officially listed to assume five major functions
Time of Update: 2021-07-06
14 Zhichun Road, Haidian District, Beijing .
The National Bureau of Disease Control and Prevention is a sub-ministerial institution under the management of the National Health Commission.
-
China CDC announces the overview of the adverse reaction monitoring of the new crown vaccination, the benefits of vaccination far outweigh the risks
Time of Update: 2021-07-06
In general reactions, about 40% of subjective symptoms such as dizziness, fatigue, or nausea are reported, and moderate to severe symptoms with objective measurement indicators such as fever, local redness, and induration are relatively rare.
-
The State Drug Administration issued a notice on the issuance of the "Administrative Measures for Drug Inspection (Trial)"
Time of Update: 2021-07-06
On May 28, in order to implement the "Drug Administration Law" and the "Vaccine Administration Law", further standardize drug inspection behavior, and promote drug supervision work as soon as possibl
-
The New Deal has landed!
Time of Update: 2021-07-06
"Dual channel" refers to the mechanism that meets reasonable needs for negotiating drug supply guarantees and clinical use through two channels, designated medical institutions and designated retail pharmacies, and simultaneously incorporates them into the medical insurance payment mechanism .
-
General Secretary Nanyang inspects important instructions: further development of Chinese medicine!
Time of Update: 2021-07-06
On the 12th, General Secretary Xi Jinping, who was investigating in Nanyang City, Henan Province, came to the Medical Sacred Shrine and Nanyang Medicine Yibao Wormwood Products Co.
to learn about the development of Chinese medicine and the wormwood product industry .
-
The State Food and Drug Administration issued an announcement on the implementation of the "Regulations on the Supervision and Administration of Medical Devices" and other matters
Time of Update: 2021-07-06
2. Regarding medical device registration and filing management Starting from June 1, 2021, before the relevant regulations for registration and filing in the new "Regulations" are issued and implemented, medical device registration applicants and filing persons will continue to apply for registration and filing in accordance with the current regulations .
-
Poinsettia Pharmaceutical Ambroxol Hydrochloride Drops Approved for Production
Time of Update: 2021-07-01
According to data from Meinenet, the terminal sales of ambroxol in China's public medical institutions exceeded 7 billion yuan in 2019 .
-
WuXi Biologics major shareholder reduces holdings and cashes in by nearly HK$11.6 billion
Time of Update: 2021-07-01
The allotment price per share was 107 Hong Kong dollars, and the cash was 11.
556 billion Hong Kong dollars .
44%, and it will continue to be the major shareholder of WuXi Biologics .
-
CPhI Pharma Online Urgent Purchase Product List 2020.04.27
Time of Update: 2021-07-01
cn] There will be free online purchasing matching activities every week.
If your company can provide the following products, please call or email us as soon as possible-the corresponding "serial number" or "name" of the product in the list; we will provide you with detailed procurement requirements and customer contact information .
-
Sichuan Huiyu Pharmaceutical Irinotecan Hydrochloride Injection Enters Administrative Approval
Time of Update: 2021-07-01
Medical Network News, March 17 Recently, Sichuan Huiyu Pharmaceutical has entered the administrative examination and approval stage with the imitation of irinotecan hydrochloride injection for production of category 4 products .
-
In-depth: Analysis report on the current status of treatment drugs for advanced liver cancer in China
Time of Update: 2021-06-30
3. Analysis of domestic approved single-drug therapy for liver cancer and its current status Targeted therapies approved for liver cancer indications in China include sorafenib, lenvatinib, regorafenib, apatinib, and carrelizumab .
-
Half-year medical commercial bribery cases will be notified into the credit rating of pharmaceutical companies
Time of Update: 2021-06-30
The National Medical Insurance Administration’s "Notice on Accelerating the Implementation of the Medical Price and Recruitment Credit Evaluation System" clearly mentioned "In accordance with the territorial principle, all provincial-level centralized procurement agencies pay close attention to the judgment documents and administrative penalty decisions published by the courts, taxation, market supervision and other departments of the region, especially the typical cases reported by the media, and promptly inquire and investigate the enterprises involved.
-
my country plans to formulate a medical security law to clarify the responsibilities of all parties
Time of Update: 2021-06-30
The "Medical Security Law (Draft for Comment)" consists of 8 chapters and 70 articles, including general provisions, financing and benefits, fund management, medical services, public management services, supervision and management, legal responsibilities, etc.
-
Mindray Medical intends to acquire Hytest Invest Oy for 545 million euros
Time of Update: 2021-06-30
Today, Mindray Medical issued an announcement stating that the company intends to use its wholly-owned subsidiary Mindray Global (Hong Kong) Co.
(English name is MR Global (HK) Limited, hereinafter referred to as “Hong Kong Global” or “wholly-owned subsidiary”) and Hong Kong The global wholly-owned subsidiary Mindray Medical Netherlands B.
-
Fermentation Equipment Chapter 1 Wang Cheng - Opening up a new world of biological fermentation equipment
Time of Update: 2021-06-30
With the theme of "Science and Technology Innovation, Intelligent Manufacturing, Energy Saving and Consumption Reduction", this exhibition provides a one-stop solution for the intelligent manufacturing of the biotechnology engineering industry .
-
The "Fourth Terminal" exploded!
Time of Update: 2021-06-30
Pharmacist Gang and Dingdang Kuaiyao's high-dollar financing has aroused heated discussions inside and outside the industry, and it also shows that the capital market is paying more and more attention to the "fourth terminal" model of online drug purchase outside hospitals .
-
Sinopharm's new crown vaccine obtains emergency use license from Thailand's Food and Drug Administration
Time of Update: 2021-06-30
It was reported on May 28 that a senior official from the Thai health department stated that the Thai Food and Drug Administration approved an emergency use license for the new crown vaccine developed by China National Pharmaceutical Group on the 28th .
-
Chinese Biomedical Space Odyssey Guide
Time of Update: 2021-06-30
In order to further understand the impact of the space environment on bone density, solve the physical health problems of astronauts, and develop new drugs for patients with osteoporosis on the ground, Amgen conducted three mouse space experiments in cooperation with NASA from 2001 to 2011 .
